Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MOBQ | Common Stock | Conversion of derivative security | $1.54M | +7.68M | +1399.21% | $0.20 | 8.22M | Aug 6, 2024 | Direct | F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MOBQ | Series H Preferred Stock | Conversion of derivative security | -752K | -56.39% | 582K | Aug 6, 2024 | Common Stock | 7.52M | $0.20 | Direct | F1, F2, F4 |
Id | Content |
---|---|
F1 | Not applicable. |
F2 | The securities listed in Table I and II are securities owned directly by Dr. Salkind and his wife and by a family trust. |
F3 | Includes dividend shares issued upon conversion. |
F4 | Includes (i) 420,000 common shares underlying convertible notes, (ii) 59,211 shares underlying warrants exercisable at $60 per share, (iii) 2,333 shares underlying options exercisable at $68.48 per share and (iv) 100,000 shares underlying options exercisable at $.20 per share. |